204 related articles for article (PubMed ID: 26905600)
1. Targeting fatty acid metabolism in heart failure: is it a suitable therapeutic approach?
Arumugam S; Sreedhar R; Thandavarayan RA; Karuppagounder V; Watanabe K
Drug Discov Today; 2016 Jun; 21(6):1003-8. PubMed ID: 26905600
[TBL] [Abstract][Full Text] [Related]
2. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.
Fukushima A; Lopaschuk GD
Biochim Biophys Acta; 2016 Oct; 1861(10):1525-34. PubMed ID: 26996746
[TBL] [Abstract][Full Text] [Related]
3. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
Fukushima A; Milner K; Gupta A; Lopaschuk GD
Curr Pharm Des; 2015; 21(25):3654-64. PubMed ID: 26166604
[TBL] [Abstract][Full Text] [Related]
4. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.
Fukushima A; Lopaschuk GD
Biochim Biophys Acta; 2016 Dec; 1862(12):2211-2220. PubMed ID: 27479696
[TBL] [Abstract][Full Text] [Related]
5. Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure.
Lopaschuk GD
Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):228-30. PubMed ID: 16959756
[TBL] [Abstract][Full Text] [Related]
6. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle.
Zhang L; Keung W; Samokhvalov V; Wang W; Lopaschuk GD
Biochim Biophys Acta; 2010 Jan; 1801(1):1-22. PubMed ID: 19782765
[TBL] [Abstract][Full Text] [Related]
7. Nuclear receptor signaling and cardiac energetics.
Huss JM; Kelly DP
Circ Res; 2004 Sep; 95(6):568-78. PubMed ID: 15375023
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic therapy for heart failure].
Loiacono F; Alberti L; Lauretta L; Puccetti P; Silipigni C; Margonato A; Fragasso G
Recenti Prog Med; 2014; 105(7-8):288-94. PubMed ID: 25072544
[TBL] [Abstract][Full Text] [Related]
9. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
Mori J; Zhang L; Oudit GY; Lopaschuk GD
J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
[TBL] [Abstract][Full Text] [Related]
10. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1.
Singh KK; Shukla PC; Yanagawa B; Quan A; Lovren F; Pan Y; Wagg CS; Teoh H; Lopaschuk GD; Verma S
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):702-9. PubMed ID: 23317938
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Energy Metabolism in Heart Failure.
Lopaschuk GD; Karwi QG; Tian R; Wende AR; Abel ED
Circ Res; 2021 May; 128(10):1487-1513. PubMed ID: 33983836
[TBL] [Abstract][Full Text] [Related]
12. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and genetic regulation of cardiac energy substrate preference.
Kodde IF; van der Stok J; Smolenski RT; de Jong JW
Comp Biochem Physiol A Mol Integr Physiol; 2007 Jan; 146(1):26-39. PubMed ID: 17081788
[TBL] [Abstract][Full Text] [Related]
14. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
[TBL] [Abstract][Full Text] [Related]
15. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
Scolletta S; Biagioli B
Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
[TBL] [Abstract][Full Text] [Related]
16. The 'Goldilocks zone' of fatty acid metabolism; to ensure that the relationship with cardiac function is just right.
Kerr M; Dodd MS; Heather LC
Clin Sci (Lond); 2017 Aug; 131(16):2079-2094. PubMed ID: 28739841
[TBL] [Abstract][Full Text] [Related]
17. Targeting mitochondrial oxidative metabolism as an approach to treat heart failure.
Fillmore N; Lopaschuk GD
Biochim Biophys Acta; 2013 Apr; 1833(4):857-65. PubMed ID: 22960640
[TBL] [Abstract][Full Text] [Related]
18. Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models.
Abdurrachim D; Luiken JJ; Nicolay K; Glatz JF; Prompers JJ; Nabben M
Cardiovasc Res; 2015 May; 106(2):194-205. PubMed ID: 25765936
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
Pellieux C; Aasum E; Larsen TS; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
J Mol Cell Cardiol; 2006 Sep; 41(3):459-66. PubMed ID: 16859699
[TBL] [Abstract][Full Text] [Related]
20. Metabolic toxicity of the heart: insights from molecular imaging.
Iozzo P
Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):147-56. PubMed ID: 20031381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]